To obtain a global view of the transcriptional changes in T-ALL with the BRD4 degrader, here we performed genome-wide gene expression profiling (GEP) of SUP-T1 cells after treatment with ARV-825 for 24 h. This evidence concerns the gene BRD4 and acute lymphoblastic leukemia.